LXRX
Closed
Lexicon Pharmaceuticals Inc
0.8841
-0.0616 (-6.51%)
Last Update: 01 Jul 2025 23:13:00
Yesterday: 0.9457
Day's Range: 0.855 - 0.9453
Send
sign up or login to leave a comment!
When Written:
2.37
Lexicon Pharmaceuticals Inc. is a biopharmaceutical company that focuses on the discovery, development, and commercialization of innovative treatments for patients with serious and life-threatening conditions. The company was founded in 1995 and is headquartered in The Woodlands, Texas.
Lexicon's primary focus is on developing drugs to treat diabetes, but the company is also involved in the development of drugs for other conditions such as neuropathic pain and carcinoid syndrome. The company has a number of drugs in various stages of development, including sotagliflozin, a drug for type 1 and type 2 diabetes, and LX9211, a drug for neuropathic pain.
Lexicon has partnerships with a number of pharmaceutical companies, including Sanofi, Ipsen, and Bristol-Myers Squibb, to help develop and commercialize its drugs. The company also has a number of patents for its drugs and technologies.
Lexicon is a publicly traded company and is listed on the Nasdaq stock exchange under the ticker symbol LXRX.
Note: This message is generated by artificial intelligence; it does not guarantee the accuracy of the information it contains and should not be considered as investment advice.
Lexicon's primary focus is on developing drugs to treat diabetes, but the company is also involved in the development of drugs for other conditions such as neuropathic pain and carcinoid syndrome. The company has a number of drugs in various stages of development, including sotagliflozin, a drug for type 1 and type 2 diabetes, and LX9211, a drug for neuropathic pain.
Lexicon has partnerships with a number of pharmaceutical companies, including Sanofi, Ipsen, and Bristol-Myers Squibb, to help develop and commercialize its drugs. The company also has a number of patents for its drugs and technologies.
Lexicon is a publicly traded company and is listed on the Nasdaq stock exchange under the ticker symbol LXRX.
Note: This message is generated by artificial intelligence; it does not guarantee the accuracy of the information it contains and should not be considered as investment advice.
(0)
(0)
Send
sign up or login to leave a comment!!








